Remifentanil

Generic Name
Remifentanil
Brand Names
Ultiva
Drug Type
Small Molecule
Chemical Formula
C20H28N2O5
CAS Number
132875-61-7
Unique Ingredient Identifier
P10582JYYK
Background

Remifentanil (marketed by Abbott as Ultiva) is a potent ultra short-acting synthetic opioid given to patients during surgery for pain relief and adjunctive to an anaesthetic. Remifentanil is a specific mu-type-opioid receptor agonist which means it reduces sympathetic nervous system tone, and causes respiratory depression and analgesia.

Indication

For use during the induction and maintenance of general anesthesia.

Associated Conditions
-
Associated Therapies
Immediate postoperative analgesia therapy, Induction and Maintenance of General Anesthesia, Monitored anesthesia care sedation

Propofol-Ketamine vs Remifentanyl-Ketamine for Sedation in Pediatric Patients Undergoing Colonoscopy

First Posted Date
2015-11-11
Last Posted Date
2017-02-06
Lead Sponsor
Cukurova University
Target Recruit Count
70
Registration Number
NCT02602743
Locations
🇹🇷

Cukurova University Faculty of Medicine Research Hospital, Adana, Turkey

Influence of Depth of Anesthesia on Pupillary Reactivity to a Standardized Stimulus

First Posted Date
2015-11-03
Last Posted Date
2017-04-04
Lead Sponsor
Hôpital Armand Trousseau
Target Recruit Count
12
Registration Number
NCT02595476
Locations
🇫🇷

Departement d'anesthesie Hopital Armand Trousseau, Paris, France

Remifentanil Infusion Alone During the Closure Period for Early Emergence Following Craniotomy

Phase 4
Completed
Conditions
Interventions
First Posted Date
2015-11-01
Last Posted Date
2015-11-01
Lead Sponsor
Yeditepe University Hospital
Target Recruit Count
80
Registration Number
NCT02593942
Locations
🇹🇷

Yeditepe University Hospital, Istanbul, Turkey

Effect of Ketamine+Propofol vs Remifentanyl+Propofol on Laryngeal Mask Insertion Conditions

First Posted Date
2015-10-22
Last Posted Date
2017-05-08
Lead Sponsor
Ankara University
Target Recruit Count
50
Registration Number
NCT02583217
Locations
🇹🇷

Cigdem Yildirim Guclu, Ankara, Turkey

Pupillometry Guided Remifentanil Administration and Total Opioid Consumption During Propofol - Remifentanil TCI

First Posted Date
2015-10-15
Last Posted Date
2015-10-19
Lead Sponsor
Pr Isabelle CONSTANT
Target Recruit Count
65
Registration Number
NCT02576600
Locations
🇫🇷

Departement d'anesthesie Hopital Armand Trousseau, Paris, France

Comparison of the Efficacy of Ketamine in Pediatric Patients With Idiopathic Scoliosis After Surgery

First Posted Date
2015-10-08
Last Posted Date
2015-10-08
Lead Sponsor
Fundació Sant Joan de Déu
Target Recruit Count
48
Registration Number
NCT02571491
Locations
🇪🇸

Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain

Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass

First Posted Date
2015-10-02
Last Posted Date
2016-10-19
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
56
Registration Number
NCT02566733
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Remifentanil and Midazolam on Propofol for Loss of Consciousness

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2015-09-01
Last Posted Date
2016-06-02
Lead Sponsor
Severance Hospital
Target Recruit Count
120
Registration Number
NCT02536690
Locations
🇰🇷

Gangnam Severance hospital, Seoul, Gangnam-gu, Korea, Republic of

Myocardial Injury in Remifentanil-based Versus Sevoflurane-sufentanil Balanced Regimens in OPCAB Surgery

First Posted Date
2015-07-16
Last Posted Date
2015-07-16
Lead Sponsor
Konkuk University Medical Center
Target Recruit Count
120
Registration Number
NCT02499445
Locations
🇰🇷

Konkuk University Medical Center, Seoul, Korea, Republic of

© Copyright 2024. All Rights Reserved by MedPath